Latest Global Expansion News

Mader Group has delivered record FY25 results with revenue climbing 13% to $872.2 million and net profit rising 13%, setting the stage for a $1 billion revenue target in FY26.

CleanSpace Holdings Limited reported a 26% increase in revenue to $19.8 million for FY25, alongside a significant reduction in net loss to $478,276. The company’s strategic expansion and innovation efforts underpin its improving financial health and global market presence.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.

Rubicon Water reported a record FY25 revenue of A$69.1 million, driven by strong growth in the US and Rest of World markets, while reducing its net loss and building a robust project pipeline for FY26.

Rubicon Water Limited posted its strongest revenue since IPO at $69.1 million in FY25, driven by robust growth in the US and EMEA markets. Despite a $7 million net loss, the company improved cash flow and reduced debt, positioning itself for further global irrigation automation expansion.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

Infomedia Ltd reported solid FY25 results with revenue up 4% to $146.5 million and net profit rising 32%, driven by key product growth and a strategic AI acquisition. The company also recommended shareholder approval of a premium takeover offer from TPG Capital.

Pilbara Minerals Limited (PLS) reported a challenging FY25 marked by a 39% revenue drop and a net loss of $196 million amid falling lithium prices. Despite this, the company advanced key expansion projects, acquired a Brazilian lithium asset, and made significant sustainability strides.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

DUG Technology reported a record US$52 million order book and strong second-half momentum in FY25, driven by innovative seismic imaging technology and global office expansions despite a slight revenue dip.